시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 십이지장궤양 치료 시장 보고서(2025년)
Duodenal Ulcer Treatment Global Market Report 2025
상품코드 : 1825714
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,670,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,642,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,613,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

십이지장 궤양 치료 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 연평균 성장률(CAGR) 7.2%로 1,418억 4,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 질병 수 증가, 의료 인프라 및 의료 시설의 증가, 치료 옵션의 가용성에 대한 인식 증가, 최소침습적 시술에 대한 선호도 증가, 정부의 인식 확산 노력 증가 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 기술 발전, 프로바이오틱스 통합, 원격의료, 영양 요법, 근거 기반 진료의 통합 등을 꼽을 수 있습니다.

향후 5년간 7.2%의 성장률 전망은 지난번 예측보다 0.2% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 인도와 독일에서 조달하는 양성자 펌프 억제제(PPI)와 내시경적 지혈기구의 비용을 상승시킴으로써 미국 시장을 저해하고, 궤양 해소를 지연시키며, 소화기 내과 치료비를 상승시킬 것으로 예상됩니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

십이지장 궤양 치료 시장의 예상 성장은 담배를 피우는 사람의 증가와 관련이 있습니다. 궐련형 담배는 담배가 담긴 작은 종이를 말아서 연기를 들이마시거나 내뿜으며 피우는 담배입니다. 흡연자 증가는 문화적 요인, 공공정책, 사회경제적 조건의 영향을 받고 있습니다. 흡연자의 십이지장궤양 치료는 궤양에 특화된 치료, 금연 프로그램, 생활습관 개선, 치유를 촉진하고 재발을 예방하기 위한 지속적인 모니터링 등 철저한 접근이 필요합니다. 예를 들어, 영국 통계청 자료에 따르면, 2022년 18세 이상 성인 중 약 640만 명이 담배를 피우고 있으며, 이는 인구의 12.9%에 해당합니다. 또한 16-24세 연령층에서 전자담배 사용률은 2021년 11.1%에서 2022년 15.5%로 상승했습니다. 이러한 흡연율 증가는 십이지장 궤양 치료 시장 확대에 기여하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Duodenal ulcer treatment encompasses the methods used to heal and manage ulcers located in the duodenum, the initial segment of the small intestine. This treatment typically includes a mix of medications aimed at decreasing acid production and fostering healing, lifestyle modifications, and occasionally, treatments to eliminate Helicobacter pylori bacteria, which is a frequent cause of duodenal ulcers.

The primary treatment options for duodenal ulcers are antibiotics, proton pump inhibitors, antacids, potassium-competitive acid blockers, H2-antagonists, ulcer-protective drugs, and surgery. Antacids are specifically used to address bacterial infections such as those caused by Helicobacter pylori, which can contribute to the development of duodenal ulcers. This aids in eradicating the bacterial infection and facilitating proper ulcer healing. These treatments are applicable to both adults and the elderly, and are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The duodenal ulcer treatment market research report is one of a series of new reports from The Business Research Company that provides duodenal ulcer treatment market statistics, including duodenal ulcer treatment industry global market size, regional shares, competitors with a duodenal ulcer treatment market share, detailed duodenal ulcer treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the duodenal ulcer treatment industry. This duodenal ulcer treatment research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The duodenal ulcer treatment market size has grown strongly in recent years. It will grow from $99.99 billion in 2024 to $107.34 billion in 2025 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to increased patient preference for non-invasive treatments, growth in gastrointestinal health awareness, increase in the number of cigarette smokers, increase in the number of alcohol or tobacco consumers, and increase in the integration of digital health solutions.

The duodenal ulcer treatment market size is expected to see strong growth in the next few years. It will grow to $141.84 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to the increasing number of diseases, an increasing number of medical infrastructure and healthcare facilities, growing awareness about the availability of treatment options, growing preference for minimally invasive procedures, and increasing efforts to spread awareness by the government. Major trends in the forecast period include technological advancements, integration of probiotics, telemedicine, nutritional therapy, and evidence-based practice integration.

The forecast of 7.2% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of proton pump inhibitors (PPIs) and endoscopic hemostatic devices sourced from India and Germany, thereby delaying ulcer resolution and elevating gastroenterology treatment costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated growth in the duodenal ulcer treatment market is linked to the rising number of cigarette smokers. Cigarette smokers are individuals who regularly consume cigarettes, which are small rolls of paper filled with tobacco that are smoked by inhaling and exhaling the smoke. The rise in cigarette smoking is influenced by cultural factors, public policies, and socioeconomic conditions. Managing duodenal ulcers in smokers requires a thorough approach, including ulcer-specific treatments, smoking cessation programs, lifestyle changes, and continuous monitoring to promote healing and prevent recurrence. For example, data from the Office for National Statistics in the UK revealed that in 2022, approximately 6.4 million adults over 18 were cigarette smokers, representing 12.9% of the population. Additionally, among the 16 to 24 age group, e-cigarette use rose to 15.5% in 2022, up from 11.1% in 2021. This increase in smoking rates is contributing to the expansion of the duodenal ulcer treatment market.

Key players in the duodenal ulcer treatment market are concentrating on creating advanced products, such as combination kits for treating both duodenal ulcers and H. pylori infections, to improve ulcer healing. A combination kit generally involves a therapy that includes medications designed to heal the ulcer and eliminate the H. pylori bacteria. For example, in April 2023, Akums Drugs and Pharmaceutical Limited, an Indian pharmaceutical company, introduced an innovative combination kit for duodenal ulcers related to H. pylori infection. This kit combines three effective medications-amoxicillin, clarithromycin, and esomeprazole-to combat H. pylori bacteria and decrease gastric acid production, addressing the main causes of duodenal ulcers. The Central Drugs Standard Control Organization (CDSCO) has approved this kit for treating duodenal ulcers and eliminating H. pylori in patients with active or healed peptic ulcers.

In June 2022, Glenmark Pharmaceuticals Ltd., an Indian company specializing in duodenal ulcer treatments, acquired over-the-counter (OTC) drug products from Wockhardt Limited for an undisclosed sum. This acquisition highlights Glenmark's ongoing efforts to expand in the US OTC market and demonstrates its dedication to providing affordable, high-quality medications. Wockhardt Limited, also based in India, is a pharmaceutical and biotechnology company that offers treatments for duodenal ulcers.

Major companies operating in the duodenal ulcer treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz AG, Sun Pharmaceutical Industries Limited, Eisai Co. Ltd., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy's Laboratories Limited, Intas Pharmaceuticals Limited, Apotex Inc., Lupin Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Limited, Jubilant Pharma Limited, Torrent Pharmaceuticals Limited

North America was the largest region in the duodenal ulcer treatment market in 2024. The regions covered in the duodenal ulcer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the duodenal ulcer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The duodenal ulcer treatment market consists of revenues earned by entities by providing services such as endoscopic therapies, follow-up care, and lifestyle and dietary changes. The market value includes the value of related goods sold by the service provider or included within the service offering. The duodenal ulcer treatment market also includes sales of endoscopic devices, surgical instruments, H2-receptor antagonists, and diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Duodenal Ulcer Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on duodenal ulcer treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for duodenal ulcer treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The duodenal ulcer treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Duodenal Ulcer Treatment Market Characteristics

3. Duodenal Ulcer Treatment Market Trends And Strategies

4. Duodenal Ulcer Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Duodenal Ulcer Treatment Growth Analysis And Strategic Analysis Framework

6. Duodenal Ulcer Treatment Market Segmentation

7. Duodenal Ulcer Treatment Market Regional And Country Analysis

8. Asia-Pacific Duodenal Ulcer Treatment Market

9. China Duodenal Ulcer Treatment Market

10. India Duodenal Ulcer Treatment Market

11. Japan Duodenal Ulcer Treatment Market

12. Australia Duodenal Ulcer Treatment Market

13. Indonesia Duodenal Ulcer Treatment Market

14. South Korea Duodenal Ulcer Treatment Market

15. Western Europe Duodenal Ulcer Treatment Market

16. UK Duodenal Ulcer Treatment Market

17. Germany Duodenal Ulcer Treatment Market

18. France Duodenal Ulcer Treatment Market

19. Italy Duodenal Ulcer Treatment Market

20. Spain Duodenal Ulcer Treatment Market

21. Eastern Europe Duodenal Ulcer Treatment Market

22. Russia Duodenal Ulcer Treatment Market

23. North America Duodenal Ulcer Treatment Market

24. USA Duodenal Ulcer Treatment Market

25. Canada Duodenal Ulcer Treatment Market

26. South America Duodenal Ulcer Treatment Market

27. Brazil Duodenal Ulcer Treatment Market

28. Middle East Duodenal Ulcer Treatment Market

29. Africa Duodenal Ulcer Treatment Market

30. Duodenal Ulcer Treatment Market Competitive Landscape And Company Profiles

31. Duodenal Ulcer Treatment Market Other Major And Innovative Companies

32. Global Duodenal Ulcer Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Duodenal Ulcer Treatment Market

34. Recent Developments In The Duodenal Ulcer Treatment Market

35. Duodenal Ulcer Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기